We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Fluorescent Probe Shows Potential in Precision Cancer Diagnostics and Fluorescence-Guided Surgery

By LabMedica International staff writers
Posted on 08 Jul 2025

Hepatocellular carcinoma (HCC), a common type of liver cancer, is difficult to diagnose early and accurately due to the limitations of current diagnostic methods. More...

Glycans, carbohydrate structures present on the surface of cells, are critical to various biological processes and are often altered in cancer cells. In particular, sialylated glycans, such as sialyl Lewis x (sLex) and sialyl Lewis a (sLea), are overexpressed in liver cancer, positioning them as potential biomarkers. However, conventional techniques for detecting these glycans are complex and unsuitable for real-time imaging. This gap underscores the need for a more accessible and precise diagnostic tool to identify liver cancer and improve surgical precision. Now, researchers have successfully developed a novel fluorescent probe that is capable of precisely identifying HCC tissue.

This novel fluorescent probe, SLY (Sialyl Lewis Yellow) was developed by a research team from Pohang University of Science and Technology (POSTECH, Pohang, South Korea\) by incorporating oxaborole as a recognition moiety into a library of fluorescent probes. SLY was found to selectively target sialylated glycans on the surface of liver cancer cells, specifically sLex and sLea, which are overexpressed in hepatocellular carcinoma (HepG2) cells. Once bound, SLY enters the cells via caveolae-mediated endocytosis and accumulates in the mitochondria, providing a fluorescent signal to aid in cancer detection.

SLY was tested in both in vivo and ex vivo experiments using cryo-sectioned liver cancer tissues, which confirmed its ability to specifically label cancerous regions with high fluorescence contrast. The results, published in the Journal of the American Chemical Society, demonstrated that SLY outperforms conventional probes by clearly distinguishing tumor margins in liver tissues. This innovative probe holds strong potential for precision diagnostics and fluorescence-guided surgery, making it an important tool for the early detection of liver cancer. The researchers plan to continue exploring the application of SLY in clinical settings, potentially advancing glycan-based cancer diagnostics and precision medicine.

“SLY represents the first fluorescent probe capable of selectively identifying sialylated glycans on the cell surface with such precision, enabling the identification of liver cancer at the cellular level,” said POSTECH Professor Young-Tae Chang, who led the study. “This work opens new possibilities in glycan-based cancer diagnostics and may lay the groundwork for future applications in fluorescence-guided surgery and precision medicine.”

Related Links:
POSTECH 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.